How Sickled Red Blood Cells Stick to Blood Vessels
Image credit: MIT
One of the most common complications of sickle-cell disease occurs when deformed red blood cells clump together, blocking tiny blood vessels and causing severe pain and swelling in the affected body parts.
A new study from MIT sheds light on how these events, known as vaso-occlusive pain crises, arise. The findings also represent a step toward being able to predict when such a crisis might occur.
“These painful crises are very much unpredictable. In a sense, we understand why they happen, but we don’t have a good way to predict them yet,” says Ming Dao, a principal research scientist in MIT’s Department of Materials Science and Engineering and one of the senior authors of the study.
The researchers found that these painful events are most likely to be produced by immature red blood cells, called reticulocytes, which are more prone to stick to blood vessel walls - as published in the Proceedings of the National Academy of Sciences.
Simulating blood flow
Patients with sickle cell disease have a single mutation in the gene that encodes hemoglobin, the protein that allows red blood cells to carry oxygen. This produces misshapen red blood cells: Instead of the characteristic disc shape, cells become sickle-shaped, especially in low-oxygen conditions. Patients often suffer from anemia because the abnormal hemoglobin can’t carry as much oxygen, as well as from vaso-occlusive pain crises, which are usually treated with opioids or other drugs.
To probe how red blood cells interact with blood vessels to set off a vaso-occlusive crisis, the researchers built a specialized microfluidic system that mimics the post-capillary vessels, which carry deoxygenated blood away from the capillaries. These vessels, about 10-20 microns in diameter, are where vaso-occlusions are most likely to occur.
The microfluidic system is designed to allow the researchers to control the oxygen level. They found that when oxygen is very low, or under hypoxia, similar to what is seen in post-capillary vessels, sickle red cells are two to four times more likely to get stuck to the blood vessel walls than they are at normal oxygen levels.
When oxygen is low, hemoglobin inside the sickle cells forms stiff fibers that grow and push the cell membrane outward. These fibers also help the cells stick more firmly to the lining of the blood vessel.
“There has been little understanding of why, under hypoxia, there is much more adhesion,” Suresh says. “The experiments of this study provide some key insights into the processes and mechanisms responsible for increased adhesion.”
The researchers also found that in patients with sickle cell disease, immature red blood cells called reticulocytes are most likely to adhere to blood vessels. These young sickle red cells, just released from bone marrow, carry more cell membrane surface area than mature red blood cells, allowing them to create more adhesion sites.
“We observed the growth of sickle hemoglobin fibers stretching reticulocytes within minutes,” Papageorgiou says. “It looks like they’re trying to grab more of the surface and adhere more strongly.”
The researchers now hope to devise a more complete model of vaso-occlusion that combines their new findings on adhesion with previous work in which they measured how long it takes blood cells from sickle cell patients to stiffen, making them more likely to block blood flow in tiny blood vessels. Not all patients with sickle cell disease experience vaso-occlusion, and the frequency of attacks can vary widely between patients. The MIT researchers hope that their findings may help them to devise a way to predict these crises for individual patients.
“Blood cell adhesion is indeed a very complex process, and we had to develop new models based on such microfluidic experiments. These adhesion experiments and corresponding simulations for sickle red cells under hypoxia are quantitative and unique,” says George Karniadakis, a professor of applied mathematics at Brown University and a senior author of the study.
“The work done on sickle cell disease by Dao and Suresh over the last decade is remarkable,” says Antoine Jerusalem, an associate professor of engineering science at the University of Oxford who was not involved in the research. “This paper in particular couples numerical and experimental state-of-the-art techniques to enhance the understanding of polymerization and adhesion of these cells under hypoxia, a drastic step towards the elucidation of how vaso-occlusion can arise in sickle cell disease.”
This article has been republished from materials provided by MIT. Note: material may have been edited for length and content. For further information, please contact the cited source.
SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
May 15 - May 16, 2019